57
Participants
Start Date
June 26, 2024
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
ETD001
Twice daily doses
Placebo
Twice daily doses
Charité Universtaetsmedizin, Berlin
IRCCS Istituto Giannina Gaslini, Genova
Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico, Milan
Hôpitaux de Toulouse, Toulouse
CHU de Montpellier, Montpellier
Azienda Ospedaliera Universitaria Integrata Verona, Verona
Westdeutsches Lungenzentrum am Universitätsklinikum, Essen
Azienda Ospedaliera Universitaria Meyer, Florence
CF-Studienzentrum Universitätsklinikum Köln, Cologne
Universitätsklinikum Frankfurt, Frankfurt
IKF Pneumologie, Frankfurt
Hospices Civils de Lyon, Lyon
Hôpital Cochin, Paris
LMU Kinikum, Munich
Ospedale Pediatrico Bambino Gesù, Roma
Belfast Health and Social Care Trust, Belfast
Royal Papworth Hospital, Cambridge
All Wales Adult CF Centre, Cardiff
Queen Elizabeth University Hospital West of Scotland CF Service, Glasgow
Royal Brompton Hospital, London
Southampton General Hospital, Southampton
Lead Sponsor
Enterprise Therapeutics Ltd
INDUSTRY